Abstract:Background and objective The hypolipidemic statins have been associated with various side effects, and in some cases, adverse reactions in humans and experimental animals, such as myotoxicity, neurobehavioral toxicity, as well as liver and kidney injuries. The purpose of the present study was to examine the possibility of the induction of oxidative stress in the brain and plasma of mice dosed with single or repetitive doses of three statins (atorvastatin, simvastatin, and rosuvastatin). Methods Male Swiss-origin mice were dosed orally with single doses of each of the three statins at 500 or 1000 mg/kg of body weight. Other groups of mice were dosed orally with repeated daily doses of each of the statins at 200 mg/kg of body weight/day for 14 or 28 consecutive days. These doses of statins were chosen to not produce overt toxicity in mice within the time frame allocated for each experiment. Brain and plasma glutathione (GSH) and malondialdehyde (MDA) levels, as well as liver enzymes activities alanine transaminase (ALT) and aspartate transaminase (AST), were determined using commercial kits. Results Single-dose treatments of the mice with the statins at either 500 or 1000 mg/kg significantly and dose-dependently (p < 0.05) reduced the GSH level in the plasma and the whole brain when compared with respective control values. Atorvastatin was the least effective statin, as only the high dose achieved a significant reduction in brain GSH level in comparison with the respective control value. Repetitive administration of the three statins at 200 mg/kg of body weight/day for 14 or 28 consecutive days significantly and time-dependently reduced plasma and brain GSH levels in comparison with respective control values. The oxidative stress biomarker MDA level significantly increased in the plasma and brain of mice following single or repetitive treatments with the three statins, and the most effective one was rosuvastatin. In association with these changes, activities of the liver enzymes ALT and AST were also increased in the plasma with single and repetitive statin treatments, and the most effective one was rosuvastatin. Conclusion The data suggest an association of high doses of three statins (atorvastatin, simvastatin, and rosuvastatin) with the induction of oxidative stress manifested as GSH reduction and MDA elevation as adverse effects in the brain and plasma of mice, which suffered from the additional burden of liver injury. These effects could be the basis of an in-depth exploration of statin adverse effects in experimental animals and to find an animal model, probably the mice, for the induction of adverse effects of statins that target the brain, as well as to shed light on potential statin intolerance outcomes following single-dose treatments in this species.

Statins, 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors, Are Able to Reduce Superoxide Anion Production by NADPH Oxidase in THP-1-Derived Monocytes

Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium.

Simvastatin reduces lipoprotein-associated phospholipase A 2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway

Proteomic Analysis of Endothelial Lipid Rafts Reveals a Novel Role of Statins in Antioxidation.

Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

Effect of statin administration on the inflammatory response of monocytes in patients with atherosclerosis

Effect of simvastatin on cholesterol efflux and expression of ABCA1 and CD36 in THP-1 macrophages

Atorvastatin Attenuates Homocysteine-Induced Migration of Smooth Muscle Cells Through Mevalonate Pathway Involving Reactive Oxygen Species and P38 MAPK.

Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (Statins) Suppress Differentiation and Reduce LPS/IFNγ-Induced Cytokine Production in Human Monocyte/Macrophage Culture

EFFECTS OF CHANGE OF STATINS ON ENDOTHELIAL NITRIC OXIDE PRODUCTION IN VASCULAR ENDOTHELIAL CELLS

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy

Pravastatin inhibits CD 11b expression and adhesion of oxLDL-induced human peripheral blood monocytes to endothelium

Effect of Simvastatin on Endothelium-Dependent Vaso-Relaxation and Endogenous Nitric Oxide Synthase Inhibitor

Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus

Fluvastatin Decreases Endothelial Nitric Oxide Synthase O‐Glcnacylation by Decreasing Glucose Uptake

Simvastatin Induces Heme Oxygenase-1

Inhibitory Effects of Simvastatin on Oxidized Low-Density Lipoprotein-Induced Endoplasmic Reticulum Stress and Apoptosis in Vascular Endothelial Cells

Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress

Oxidative Stress-Induced Adverse Effects of Three Statins Following Single or Repetitive Treatments in Mice

Atorvastatin Attenuates Homocysteine-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Via Inhibiting NADPH Oxidase-Related Oxidative Stress-Triggered P38mapk Signaling

E0070 Atorvastatin Suppresses Inflammatory Response Induced by Oxldl Through Inhibition of ERK Phosphorylation, IκB? Degradation and COX-2 Expression in Murine Macrophages